Aims: Hypothyroidism is a disease that affects numerous people all over the world. The treatment is based on supplementation of thyroid hormones, however recent clinical trials, meta-analyses, and systematic reviews provide new insights about the role of micronutrients in this disease. Nevertheless, there are inconsistencies in the literature regarding the efficacy and necessity of supplementing these micronutrients in patients with hypothyroidism. The motivation to broach this topic was the dynamic growth of the dietary supplements market and the interest we observed among patients regarding the use of supplements in our clinical practice. Our goal is to evaluate the latest literature regarding the role of supplementation of iron, selenium, zinc and iodine in patients with hypothyroidism and its practical significance for healthcare professionals. Methods: The literature review was conducted using the PubMed and Google Scholar database. Publications from 2016–2024 were searched using specific keywords. Results: Hypothyroidism negatively affects iron metabolism, conversely iron deficiency impacts negatively the thyroid function. However, we have found only one prospective study showing benefits of iron supplementation in hypothyroidism patients. Selenium supplementation in hypothyroidism reduces TSH levels, this effect is intensified by co-supplementation of myo-inositol. No impact of selenium supplementation on T3 and T4 levels was described; also the impact on quality of life is controversial. There is still a lack of definitive evidence regarding the positive effects of zinc supplementation in hypothyroidism. Although both iodine deficiency and excessive iodine intake can lead to hypothyroidism, the impact of iodine supplementation specifically in patients with hypothyroidism remains unclear. Conclusions: The microelements have clinical impact on function, metabolism and conversion of thyroid hormones; however the effectiveness of supplementation in hypothyroidism has not been broadly examined.
Historia monitorowania przewodnictwa nerwowo-mięśniowego sięga XVI wieku, kiedy prowadzono badania nad kurarą, używaną przez Indian do zatruwania strzał. Późniejsze analizy umożliwiły opisanie zjawiska złącza nerwowo-mięśniowego, jednak dopiero w XX wieku udało się sprecyzować rolę mediatora, jakim jest acetylocholina. Pomiar przewodnictwa nabierał coraz większego znaczenia klinicznego, gdy okazało się, że prawie połowa pacjentów, którzy otrzymali długodziałający środek zwiotczający mięśnie, trafiała na salę pooperacyjną z niepełnym ustąpieniem blokady nerwowo-mięśniowej. Obecnie urządzenia do pomiaru przewodnictwa nerwowo-mięśniowego wykorzystujące akceleromiografię stają się standardowym wyposażeniem bloku operacyjnego.
Aims: Purpose of this case report is to increase awareness of a rare zoledronic acid side effect which is acute anterior uveitis. We would like to educate both clinicians and patients about possible ocular symptoms that can occur after zoledronic acid administration. As an effect when patients develop these symptoms, they can get optimal medical care as soon as possible and minimize the risk of severe ocular complications. Case Description: We report a case of an unilateral acute anterior uveitis in a 69 years old woman with osteoporosis secondary to breast cancer treatment who presented with flu-like symptoms accompanied by visual symptoms such as redness, pain and foreign body feeling in the right eye after receiving zoledronic acid infusion. Other causes of uveitis were excluded and after proper treatment symptoms reduced. Outcomes: The inflammation resolved within two weeks of treatment, with no recurrence or long-term complications during follow-up. Posterior synechiae were successfully released, and visual acuity returned to baseline. Conclusions: Although the risk of acute anterior uveitis after zoledronic acid infusion is low, it is essential that patients receiving this kind of treatment were properly informed about possible ocular side effects and need for ophthalmological visit if any eye symptoms occur to ensure early diagnosis and prompt accurate treatment.